GlassScriptPhysician profile
Asmita R Patel
NPI 1134240252
$1,908.01
in general payments reported to CMS, 2019-2025
9 companies · $1,077 in 2025
The $1,077 reported for 2025 was more than what 95% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $138 · 2023: $581 · 2024: $111 · 2025: $1,077.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,000 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $550 · Food and Beverage: $220.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,000.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $550.00 |
| Food and Beverage | $219.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $1,000.00 | 2025 | |
| Becton, Dickinson and Company | $550.00 | 2023 | |
| Horizon Therapeutics Plc | $138.30 | 2022 | |
| Boston Scientific Corporation | $61.45 | 2024-2025 | Varithena Administration Pack |
| Medtronic, INC. | $49.57 | 2025 | Venaseal |
| Novartis Pharmaceuticals Corporation | $31.48 | 2023 | |
| Tactile Systems Technology INC | $29.89 | 2024 | Flexitouch Plus, Entre Plus |
| Bard Peripheral Vascular, INC. | $24.99 | 2024 | Venclose Maven Catheter |
| Amgen INC. | $22.33 | 2024 | Krystexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Asmita Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.